These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2468859)

  • 1. Effects of nitrendipine on blood pressure, renin-angiotensin system, and kidney function in essential hypertension.
    Glorioso N; Manunta P; Troffa C; Pazzola A; Soro A; Pala F; Melis MG; Madeddu P; Tonolo G
    J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S142-5. PubMed ID: 2468859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of single and repeated doses of the calcium antagonist felodipine on blood pressure, renal function, electrolytes and water balance, and renin-angiotensin-aldosterone system in hypertensive patients.
    Leonetti G; Gradnik R; Terzoli L; Fruscio M; Rupoli L; Cuspidi C; Sampieri L; Zanchetti A
    J Cardiovasc Pharmacol; 1986; 8(6):1243-8. PubMed ID: 2434753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal effects of nitrendipine.
    Ruilope LM
    J Cardiovasc Pharmacol; 1991; 18 Suppl 5():S10-3. PubMed ID: 1725795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of nitrendipine on blood pressure, renin-angiotensin-system and atrial natriuretic peptide in hypertensive type I diabetic patients.
    Lehnert H; Schmitz H; Preuss K; Küstner E; Krause U; Beyer J
    Horm Metab Res; 1993 Jan; 25(1):24-8. PubMed ID: 8428706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of captopril on renal haemodynamics and the renin-angiotensin-aldosterone and osmoregulatory systems in essential hypertension.
    Thomsen OO; Danielsen H; Sørensen SS; Pedersen EB
    Eur J Clin Pharmacol; 1986; 30(1):1-6. PubMed ID: 3519238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal effects of captopril and nitrendipine in transgenic rats with an extra renin gene.
    Hirth-Dietrich C; Stasch JP; Ganten D; Luft FC
    Hypertension; 1994 May; 23(5):626-31. PubMed ID: 8175172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitrendipine vs. captopril in essential hypertension: effects on circadian blood pressure and left ventricular hypertrophy.
    Machnig T; Henneke KH; Engels G; Pongratz G; Schmalzl M; Gellert J; Bachmann K
    Cardiology; 1994; 85(2):101-10. PubMed ID: 7954561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
    Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in plasma norepinephrine concentration and thrombocyte alpha 2-adrenoceptor density during long-term antihypertensive therapy with nitrendipine and captopril.
    Müller R; Steffen HM; Weller P; Kugel C; Freiheit T; Krone W
    J Cardiovasc Pharmacol; 1994 Sep; 24(3):429-33. PubMed ID: 7528299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of PG synthesis by indomethacin does not influence the exercise induced stimulation of renin-angiotensin-aldosterone system in hypertensives treated with captopril.
    Novo S; Adamo L; Nardi E; Licata G; Strano A
    Prog Clin Biol Res; 1987; 242():387-92. PubMed ID: 3313416
    [No Abstract]   [Full Text] [Related]  

  • 11. Antihypertensive treatment using calcium antagonists in combination with captopril rather than diuretics.
    Brouwer RM; Bolli P; Erné P; Conen D; Kiowski W; Bühler FR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S88-91. PubMed ID: 2580183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal characteristics and effect of angiotensin suppression in oral contraceptive users.
    Ribstein J; Halimi JM; du Cailar G; Mimran A
    Hypertension; 1999 Jan; 33(1):90-5. PubMed ID: 9931087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium channel blockade with nitrendipine. Effects on sodium homeostasis, the renin-angiotensin system, and the sympathetic nervous system in humans.
    Luft FC; Aronoff GR; Sloan RS; Fineberg NS; Weinberger MH
    Hypertension; 1985; 7(3 Pt 1):438-42. PubMed ID: 3158605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Converting enzyme inhibition in mild and moderate essential hypertension. II.
    Rasmussen S; Leth A; Ibsen H; Damkjaer Nielsen M; Nielsen F; Giese J
    Acta Med Scand; 1986; 219(1):29-36. PubMed ID: 3006449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.
    Iimura O; Shimamoto K
    Adv Exp Med Biol; 1989; 247A():39-48. PubMed ID: 2532450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the efficacy and tolerability of nitrendipine in reducing both pressure and left ventricular mass in hypertensive type 2 diabetic patients.
    Scognamiglio R; Nosadini R; Marin M; Nisti S; Fasoli G; Palisi M; Frigato F; Virgili F; Carraro A; Crepaldi G
    Diabetes Care; 1997 Aug; 20(8):1290-2. PubMed ID: 9250456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal hemodynamics in essential and renovascular hypertension. Influence of captopril.
    Hollenberg NK
    Am J Med; 1984 May; 76(5B):22-8. PubMed ID: 6328983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of felodipine on natriuresis, atrial natriuretic factor, the renin-angiotensin-aldosterone system, and blood pressure in essential hypertension.
    Cerasola G; Cottone S; Mangano MT; D'Ignoto G; Pinto A; Carone MB
    Clin Ther; 1988; 10(6):694-703. PubMed ID: 2975530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Captopril in the treatment of arterial hypertension in chronic nephritis].
    Kutyrina IM; Rogov VA; Lifshits NL; Klepikov PV
    Ter Arkh; 1986; 58(8):92-6. PubMed ID: 3532416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between vasopressin and the renin-angiotensin-aldosterone system in essential hypertension: effect of converting enzyme inhibitor on plasma vasopressin.
    Santucci A; Leonetti Luparini R; Ferri C; Ficara C; Giarrizzo C; Balsano F
    J Hypertens Suppl; 1985 Nov; 3(2):S133-4. PubMed ID: 3003302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.